Menarini

August 30, 2018

Seeking alpha in PI3K inhibition

Novartis hails the most advanced alpha-directed PI3K inhibitor after success in breast cancer, but it’s not the only one.

May 22, 2018

Asco preview – A second wind for antibody-drug conjugates

June 27, 2017

Aveo comeback highlights a transatlantic split

Most drugs get the nod in the US before Europe – but there are some cases where the usual trend is reversed.

June 27, 2017

Aveo comeback highlights a transatlantic split

After the recent EU positive opinion for Aveo's tivozanib, EP Vantage takes a look at other projects approved in the EU, but not the US.

December 14, 2015

Horizon pays $500m for gout clout

February 20, 2014

Mid-cap consolidation spree looks set to yield bigger deals

February 06, 2014

Therapeutic focus – Diarrhoea-predominant IBS market firms up

October 14, 2013

Vivus ticks the US Stendra box

July 22, 2013

Vivus won’t be fixed overnight, but here’s a plan